Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIVER AKI: Human Albumin vs Saline in Decompensated Cirrhosis and AKI
NCT07270874Phase 4Not yet recruiting
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Jan 2026
- Primary completion
- Aug 2027
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 4 trial of albumin (human) in acute kidney injury (AKI), decompensated cirrhosis, sponsored by Fundació Clínic per a la Recerca Biomèdica. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
albumin (human)
03
Conditions
acute kidney injury (AKI)decompensated cirrhosis
Beyond the preview
Go deeper on NCT07270874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07270874.